As controversy swirls around the vaping industry, a team of Cornell researchers has set out to help regulators identify the most effective health warnings to include in advertisements for electronic cigarettes.
A new Cleveland Clinic study has uncovered a genetic anomaly associated with poor response to a common asthma treatment. The findings, published in Proceedings of the National Academy of Sciences, showed that asthmatic patients with the gene variant are less likely to respond to glucocorticoids and often develop severe asthma.
Nearly half of the disparity in later-stage diagnosis was mediated by being uninsured or underinsured, according to a new study conducted at the University of Illinois at Chicago and Boston Medical Center/Boston University School of Medicine.
The quest to conquer cancer is motivating a team of researchers at the University of Oklahoma to develop a 3D scanner capable of guiding the radiation treatment, dispensing just the right amount of radiation to just the precise location, making real-time adjustments as treatment is delivered.
In Southern states that expanded their Medicaid programs under the Affordable Care Act, adults experienced lower rates of decline in both physical and mental health, according to research published this month in the journal Health Affairs.
Proof-of-concept research points to wearable temperature monitors’ potential to offer low-cost, non-invasive way to detect GVHD, a dangerous bone-marrow transplant complication.
A new study revealed that one dose of the HPV vaccine may prevent infection from the potential cancer-causing virus, according to research published in JAMA Network Open from The University of Texas Health Science Center at Houston (UTHealth).
An innovative approach to analyzing the medical scans of patients in clinical trials could help ensure the accuracy of trial results while reducing the workload for busy oncologists, according to a new study by researchers at the University of Michigan Rogel Cancer Center.
MRI and an emerging field of medicine called radiomics could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease, according to a Penn Medicine study.
In the next five years, the NACP will focus the program's immediate priorities on enhancing the partnership with the University of Arizona Cancer Center to make a greater impact in addressing cancer health disparities for Native Americans in Arizona and throughout the Southwest.
A research team led by Dr. Dean Tang at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer.
Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and spread, and so restarting that process could leave these cancers vulnerable to a variety of treatments
Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). The results of their study will be published in the November issue of the Journal of the National Cancer Institute.
Signaling a potential major change in cervical cancer screening options for American women, a new study found that mailed self-sampling kits that test for HPV — the virus that can cause cervical cancer — helped significantly more women get screened for the cancer.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
Cancer-control researchers at the University of Kentucky Markey Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a $5.7 million grant from the National Cancer Institute.
One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey expert shares more on their role in patient care.
The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.
The National Cancer Institute has awarded a four-year, more than $1.87 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to study the impact of implementing financial navigation services at five rural cancer centers in North Carolina to help patients cope with the financial burden, or financial toxicity, related to cancer care.
To bridge the gap between cancer interventions and their implementation within communities across the country, the National Institute of Health’s National Cancer Institute is funding the creation of six implementation science centers focused on cancer control. The creation of these centers are part of NIH’s Cancer Moonshot initiative to make more therapies available and improve prevention and detection. One of the six centers will be at the UW.
AACI will present 2019 Public Service Awards to U.S. Representatives Kathy Castor (D-FL) and Fred Upton (R-MI) on Monday, October 21, during the AACI/CCAF Annual Meeting at The Mayflower Hotel in Washington, DC.
In a study published online today by the journal Cancer, investigators at Dana-Farber Cancer Institute report that a single-session sleep education program for survivors can cure insomnia in many participants, and that those who don’t benefit from this approach are often helped by a more extensive, but still modest, three-session program.
Michigan's two comprehensive cancer center, the University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer Institute, have received a prestigious $9.2 million grant from the National Cancer Institute for prostate cancer research.
A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.
In a study published in the journal Cancer Immunology Research, University of North Carolina Lineberger Comprehensive Cancer Center researchers reported on the discovery of a method for predicting whether abnormal proteins produced by cancer cells could trigger an immune response.
Researchers at the Johns Hopkins Kimmel Cancer Center discovered that a cell adhesion protein, E-cadherin, allows breast cancer cells to survive as they travel through the body and form new tumors, a process termed metastasis.
Mayo Clinic announced today that Mayo Clinic Cancer Center has successfully renewed funding for its Cancer Center Support Grant from the National Cancer Institute (NCI). The NCI grant award provides approximately $28.7 million in funding over five years through 2024, which will mark the center’s 49th year of NCI funding.